Connecticut SB 260: AN ACT CONCERNING A PRESCRIPTION DRUG COST CONTROL BOARD.

Status: PUBLIC HEARING 0308 (as of 2022-03-04)

State: Connecticut · Session: 2022 · Bill: SB 260

Subjects: Councils, Drugs, Insurance Department, Medical expenses, Pharmaceutical industry, Quasi-public agencies, Reports, State boards and commissions

Sponsors: Nolan, Anthony L., Palm, Christine, Smith, Brian T., Winkler, Michael A.

View Connecticut SB 260 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.